JAKKS Pacific is rated a BUY due to its strong earnings performance, debt-free balance sheet, and a 4% dividend yield. The company benefits from upcoming catalysts such as new Frozen and Sonic the Hedgehog films and expansion into manga and anime intellectual properties, which support future revenue growth. Its asset-light, FOB distribution model reduces inventory risk and drives strong cash flow, with rapid growth in international sales. However, risks include high customer concentration at Walmart and Target and dependence on new IP launches for sustained growth.
JAKKS Pacific stock is the subject here, with Pluang providing a snapshot of the Consumer Cyclical sector as of Sep 29, 2026 09:51 WIB: out of 112 priced stocks, 35 rose and 73 fell. Among notable movers, SFIX gained 14.62% to USD 2.47 with a typical hold time of 30 days and a balanced buy/sell order activity, contrasting with QS which dropped 7.33% to USD 4.55 despite 97% buy orders and a longer hold time of 36 days, and CVNA which fell 6.93% to USD 60.55 but saw 100% buy orders and a 28-day hold time.
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
